PWM
NVAX icon

Perigon Wealth Management’s Novavax NVAX Stock Holding History

Perigon Wealth Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,041
Closed -$298K – 605
2022
Q1 		$298K Buy
4,041
+120
+3% +$10.7K 0.02% 458
2021
Q4 		$561K Buy
3,921
+3
+0.1% +$515 0.04% 320
2021
Q3 		$812K Buy
3,918
+11
+0.3% +$2.42K 0.07% 227
2021
Q2 		$829K Sell
3,907
-398
-9% -$72.9K 0.07% 226
2021
Q1 		$781K Sell
4,305
-401
-9% -$79.9K 0.08% 213
2020
Q4 		$525K Buy
4,706
+3,900
+484% +$415K 0.06% 241
2020
Q3 		$87K Buy
806
+6
+0.8% +$731 0.01% 376
2020
Q2 		$67K Buy
+800
New +$30.6K 0.01% 352

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perigon Wealth Management's NVAX Position: Q2 2022 in Review

Perigon Wealth Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 4,041 shares — an estimated $298K sold.

Perigon Wealth Management first reported a position in NVAX in Q2 2020 and held it in 8 quarters. The position peaked at $829K in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Perigon Wealth Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Perigon Wealth Management sold 4,041 Novavax shares in Q2 2022, an estimated $298K.
  • Perigon Wealth Management first reported a position in Novavax in Q2 2020 and held it in 8 quarters.
  • Perigon Wealth Management's Novavax position peaked at $829K in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Perigon Wealth Management's 13F filing for Q2 2022, filed 11 Aug 2022.